Rotavirus

Pediatrics in Review

Volumn 33, Issue 10, 2012, Pages 439-447

  Cox, Elaine ^a   Christenson, John C ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOUBLE STRANDED RNA; IMMUNOGLOBULIN; INFUSION FLUID; NITAZOXANIDE; ORAL REHYDRATION SOLUTION; PROBIOTIC AGENT; ROTAVIRUS VACCINE;

ARTICLE; CD8+ T LYMPHOCYTE; CLINICAL FEATURE; DIARRHEA; DISEASE SEVERITY; ELECTRON MICROSCOPY; ENZYME IMMUNOASSAY; GENOTYPE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INCIDENCE; INCUBATION TIME; INFECTION CONTROL; INTUSSUSCEPTION; LENGTH OF STAY; NASOGASTRIC TUBE; NONHUMAN; ORAL REHYDRATION THERAPY; PATHOGENESIS; POLYMERASE CHAIN REACTION; ROTAVIRUS; ROTAVIRUS INFECTION; SENSITIVITY AND SPECIFICITY; SEROLOGY; SEVERE COMBINED IMMUNODEFICIENCY; VIRAL GASTROENTERITIS; VIROLOGY; VIRUS TRANSMISSION;

GASTROENTERITIS; HUMANS; INFANT; ROTAVIRUS; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES;

EID: 84867374951     PISSN: 01919601     EISSN: 15263347     Source Type: Journal    
DOI: 10.1542/pir.33-10-439     Document Type: Article

References (14)

1. Koch J, Wiese-Posselt M. Epidemiology of rotavirus infections in children less than 5 years of age: Germany, 2001-2008. Pediatr Infect Dis J. 2011;30(2):112-117
2. Curns AT, Panozzo CA, Tate JE, et al. Remarkable postvaccination spatiotemporal changes in United States rotavirus activity. Pediatr Infect Dis J . 2011;30(suppl 1):S54-S55
3. Snelling TL, Andrews RM, Kirkwood CD, Culvenor S, Carapetis JR. Case-control evaluation of the effectiveness of the G1P [8] human rotavirus vaccine during an outbreak of rotavirus G2P [4] infection in central Australia. Clin Infect Dis. 2011;52(2):191-199
4. Ruiz-Palacios GM, Pérez-Schael I, Velázquez FR, et al; Human Rotavirus Vaccine Study Group. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med. 2006;354(1):11-22
5. Vesikari T, Matson DO, Dennehy P, et al Rotavirus Efficacy and Safety Trial (REST) Study Team. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med. 2006;354(1):23-33 (Pubitemid 43048948)
6. Patel MM, López-Collada VR, Bulhões MM, et al. Intussusception risk and health bene fits of rotavirus vaccination in Mexico and Brazil. N Engl J Med. 2011;364(24):2283-2292
7. Madhi SA, Cunliffe NA, Steele D, et al. Effect of human rotavirus vaccine on severe diarrhea in African infants. N Engl J Med. 2010;362(4):289-298
8. Richardson V, Hernandez-Pichardo J, Quintanar-Solares M, et al. Effect of rotavirus vaccination on death from childhood diarrhea in Mexico. N Engl J Med. 2010;362(4):299-305
9. Bégué RE, Perrin K. Reduction in gastroenteritis with the use of pentavalent rotavirus vaccine in a primary practice. Pediatrics. 2010;126(1):e40-e45
10. Curns AT, Steiner CA, Barrett M, Hunter K, Wilson E, Parashar UD. Reduction in acute gastroenteritis hospitalizations among US children after introduction of rotavirus vaccine: analysis of hospital discharge data from 18 US states. J Infect Dis. 2010;201(11):1617-1624
11. Yen C, Armero Guardado JA, Alberto P, et al. Decline in rotavirus hospitalizations and health care visits for childhood diarrhea following rotavirus vaccination in El Salvador. Pediatr Infect Dis J. 2011;30(suppl 1):S6-S10
12. Becker-Dreps S, Paniagua M, Dominik R, et al. Changes in childhood diarrhea incidence in Nicaragua following 3 years of universal infant rotavirus immunization. Pediatr Infect Dis J. 2011;30(3):243-247
13. Anderson EJ, Rupp A, Shulman ST, Wang D, Zheng X, Noskin GA. Impact of rotavirus vaccination on hospital-acquired rotavirus gastroenteritis in children. Pediatrics. 2011;127(2):e264-e270
14. Yen C, Tate JE, Wenk JD, Harris JM II, Parashar UD. Diarrhea-associated hospitalizations among US children over 2 rotavirus seasons after vaccine introduction. Pediatrics. 2011;127(1):e9-e15